YY1: a key regulator inhibits gastric cancer ferroptosis and mediating apatinib-resistance.

Authors:
Geng ZH; Du JX; Chen YD; Fu PY; Zhou PH and 2 more

Journal:
Cancer Cell Int

Publication Year: 2024

DOI:
10.1186/s12935-024-03262-z

PMCID:
PMC10863212

PMID:
38347631

Journal Information

Full Title: Cancer Cell Int

Abbreviation: Cancer Cell Int

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateExperimental protocols were approved by the Ethics Committee of Zhongshan Hospital in accordance with the National Institutes of Health. Consent for publicationWe have obtained consents to publish this paper from all the participants of this study. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This study was supported by Natural Science Foundation of China (82003083)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025